SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-012790
Filing Date
2018-11-15
Accepted
2018-11-15 08:01:44
Documents
3
Period of Report
2018-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT gtbp_8k.htm 8-K 21640
2 PRESS RELEASE gtbp_ex991.htm EX-99.1 154921
3 IMAGE gtbp_ex991000.jpg GRAPHIC 1972
  Complete submission text file 0001654954-18-012790.txt   180875
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-08092 | Film No.: 181185989
SIC: 2834 Pharmaceutical Preparations